Literature DB >> 9762023

Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome.

Y Suzuki1, R Inagi, T Aono, K Yamanishi, T Shiohara.   

Abstract

BACKGROUND: Drug-induced hypersensitivity syndrome is characterized by a severe, potentially fatal, multiorgan hypersensitivity reaction that usually appears after prolonged exposure to certain drugs. Its delayed onset and clinical resemblance to infectious mononucleosis suggest that underlying viral infections may trigger and activate the disease in susceptible individuals receiving these drugs. OBSERVATIONS: A 60-year-old woman developed an itchy, generalized, erythematous, confluent rash on the 39th day of receiving allopurinol therapy. Even after she discontinued treatment with allopurinol, her skin lesions progressed to severe blistering skin eruption. After the patient started oral prednisone therapy, her skin lesions resolved with desquamation. After complete resolution, rechallenge with allopurinol led to the development of an erythematous eruption. Titers of human herpesvirus 6 IgG antibodies dramatically increased with the development of the eruption. The results of a polymerase chain reaction and in situ hybridization indicated the presence of human herpesvirus 6 in the skin lesions, although human herpesvirus 7 DNA was detected only by in situ hybridization.
CONCLUSION: Reactivation of human herpesvirus 6, possibly in concert with human herpesvirus 7, can contribute to the development of a severe drug-induced hypersensitivity syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762023     DOI: 10.1001/archderm.134.9.1108

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  43 in total

1.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; C Burkhart; A E Cribb; W J Pichler; B K Park
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  ATL-like marked atypical lymphocytosis associated with drug-induced hypersensitivity syndrome and human herpesvirus-6 reactivation.

Authors:  Tomonori Nakazato; Kazuhito Suzuki; Ai Mihara; Yukinari Sanada; Yoshinobu Aisa; Tsunayuki Kakimoto
Journal:  Int J Hematol       Date:  2009-11-25       Impact factor: 2.490

3.  Evidence for reactivation of human herpesvirus 6 in generalized lymphadenopathy in a patient with drug-induced hypersensitivity syndrome.

Authors:  Takeshi Saraya; Michiaki Mikoshiba; Harumi Kamiyama; Masakazu Yoshizumi; Shigeru Tsuchida; Hiroyuki Tsukagoshi; Taisei Ishioka; Miho Terada; Eiichi Tanabe; Chizuko Tomioka; Haruyuki Ishii; Hirokazu Kimura; Kunihisa Kozawa; Tetsuo Shiohara; Hajime Takizawa; Hajime Goto
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

Review 4.  Skin manifestations of drug allergy.

Authors:  Michael R Ardern-Jones; Peter S Friedmann
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 5.  Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.

Authors:  Ivan Gentile; Maria Talamo; Guglielmo Borgia
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

Review 6.  Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; B K Park
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

7.  Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.

Authors:  Brian Yan; Yvette Leung; Stefan J Urbanski; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

8.  Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutralizing antibodies contribute to sequential infection with these viruses in childhood.

Authors:  Mariko Yoshida; Sadayoshi Torigoe; Kumiko Ikeue; Masao Yamada
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

9.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 10.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.